Home Banner



Global Healthcare Nanotechnology (Nanomedicine) Market Size study, by Diseases (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases and Others), Application (Drug Delivery, Biomaterials, Active Implants and Others) and Regional Forecasts 2020-2027


ID : 63179 Date : Apr 2021 Pages : 200 Pages Publisher : BRCLLP Industry : Material and Chemicals




Global Healthcare Nanotechnology Nanomedicine Market is valued approximately USD 196.47 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9 % over the forecast period 2020-2027. Healthcare Nanotechnology Nanomedicine is the product which is nano-formulations of the existing drugs or new drugs or nanomaterials. Nanomedicine helps in improving human health by providing solutions for various life-threatening diseases, like cancer, Parkinson’s disease, Alzheimer’s disease, diabetes, orthopedic diseases, and infections blood, lungs, and cardiovascular system. For instance: according to the Alzheimers Disease International, there were around 50 million people globally with dementia in 2020, which is expected to double every 20 years. According to the Globocan 2020, the global cancer burden increased to 19.3 million cases and 10 million cancer deaths in 2020. This will increase the demand for effective nanomedicines in the management of the diseases. Further, increasing investments in urgent care, increasing geriatric population and strategic development between hospitals and the manufacturers has led the adoption of Healthcare Nanotechnology Nanomedicine across the forecast period. The market has seen positive growth due to investments in new products by research & development. For Instance: in 2020, Medtronic PLC launched navigated titanium spinal implant, its new Adaptix Interbody System which is with the Titan nanoLOCK Surface Technology. In 2019, Nanobiotix, a clinical stage nanomedicine company had obtained the CE approval for its Hensify NBTXR3, nanoparticles designed for injection directly into a tumor. However, stringent regulatory issues and high cost of nano-medicines compared to the traditional medicines along with low awareness among consumers in low income countries impedes the growth of the market over the forecast period of 2020-2027. Also, with the increasing prevalence of diseases, technological advancements for early disease diagnosis & preventive intervention the adoption & demand for Healthcare Nanotechnology Nanomedicine is likely to increase.

The regional analysis of global Healthcare Nanotechnology Nanomedicine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of nano-medicines coupled with the well-established healthcare infrastructure along with the huge investments in research & development activities. For instance: according to the www.acc.org, in 2018, coronary heart disease was the leading cause of deaths attributable to cardiovascular disease in the United States with 43.8% of total CVD deaths. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rise in research grants, increasing venture capital investors from developing economies of this region and increasing international research collaborations along with the improving healthcare infrastructure would create lucrative growth prospects for the Healthcare Nanotechnology Nanomedicine market across Asia-Pacific region.

Major market player included in this report are:
Abbott Laboratories
CombiMatrix Corporation
GE Healthcare
Sigma-Tau Pharmaceuticals, Inc.
Johnson & Johnson
Mallinckrodt plc
Merck & Company, Inc.
Nanosphere, Inc.
Pfizer, Inc.
Celgene Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Diseases:
Cardiovascular Diseases
Oncological Diseases
Neurological Diseases
Others
By Application:
Drug Delivery
Biomaterials
Active Implants
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Healthcare Nanotechnology Nanomedicine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers VARs
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 USD Billion
1.2.1. Healthcare Nanotechnology Nanomedicine Market, by Region, 2018-2027 USD Billion
1.2.2. Healthcare Nanotechnology Nanomedicine Market, by Diseases, 2018-2027 USD Billion
1.2.3. Healthcare Nanotechnology Nanomedicine Market, by Application, 2018-2027 USD Billion
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Healthcare Nanotechnology Nanomedicine Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Healthcare Nanotechnology Nanomedicine Market Dynamics
3.1. Healthcare Nanotechnology Nanomedicine Market Impact Analysis 2018-2027
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Healthcare Nanotechnology Nanomedicine Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model 2017-2027
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Healthcare Nanotechnology Nanomedicine Market, by Diseases
5.1. Market Snapshot
5.2. Global Healthcare Nanotechnology Nanomedicine Market by Diseases, Performance - Potential Analysis
5.3. Global Healthcare Nanotechnology Nanomedicine Market Estimates & Forecasts by Diseases 2017-2027 USD Billion
5.4. Healthcare Nanotechnology Nanomedicine Market, Sub Segment Analysis
5.4.1. Cardiovascular Diseases
5.4.2. Oncological Diseases
5.4.3. Neurological Diseases
5.4.4. Others
Chapter 6. Global Healthcare Nanotechnology Nanomedicine Market, by Application
6.1. Market Snapshot
6.2. Global Healthcare Nanotechnology Nanomedicine Market by Application, Performance - Potential Analysis
6.3. Global Healthcare Nanotechnology Nanomedicine Market Estimates & Forecasts by Application 2017-2027 USD Billion
6.4. Healthcare Nanotechnology Nanomedicine Market, Sub Segment Analysis
6.4.1. Drug Delivery
6.4.2. Biomaterials
6.4.3. Active Implants
6.4.4. Others
Chapter 7. Global Healthcare Nanotechnology Nanomedicine Market, Regional Analysis
7.1. Healthcare Nanotechnology Nanomedicine Market, Regional Market Snapshot
7.2. North America Healthcare Nanotechnology Nanomedicine Market
7.2.1. U.S. Healthcare Nanotechnology Nanomedicine Market
7.2.1.1. Diseases breakdown estimates & forecasts, 2017-2027
7.2.1.2. Application breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Healthcare Nanotechnology Nanomedicine Market
7.3. Europe Healthcare Nanotechnology Nanomedicine Market Snapshot
7.3.1. U.K. Healthcare Nanotechnology Nanomedicine Market
7.3.2. Germany Healthcare Nanotechnology Nanomedicine Market
7.3.3. France Healthcare Nanotechnology Nanomedicine Market
7.3.4. Spain Healthcare Nanotechnology Nanomedicine Market
7.3.5. Italy Healthcare Nanotechnology Nanomedicine Market
7.3.6. Rest of Europe Healthcare Nanotechnology Nanomedicine Market
7.4. Asia-Pacific Healthcare Nanotechnology Nanomedicine Market Snapshot
7.4.1. China Healthcare Nanotechnology Nanomedicine Market
7.4.2. India Healthcare Nanotechnology Nanomedicine Market
7.4.3. Japan Healthcare Nanotechnology Nanomedicine Market
7.4.4. Australia Healthcare Nanotechnology Nanomedicine Market
7.4.5. South Korea Healthcare Nanotechnology Nanomedicine Market
7.4.6. Rest of Asia Pacific Healthcare Nanotechnology Nanomedicine Market
7.5. Latin America Healthcare Nanotechnology Nanomedicine Market Snapshot
7.5.1. Brazil Healthcare Nanotechnology Nanomedicine Market
7.5.2. Mexico Healthcare Nanotechnology Nanomedicine Market
7.6. Rest of The World Healthcare Nanotechnology Nanomedicine Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial Subject to Data Availability
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. CombiMatrix Corporation
8.2.3. GE Healthcare
8.2.4. Sigma-Tau Pharmaceuticals, Inc.
8.2.5. Johnson & Johnson
8.2.6. Mallinckrodt plc
8.2.7. Merck & Company, Inc.
8.2.8. Nanosphere, Inc.
8.2.9. Pfizer, Inc.
8.2.10. Celgene Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
List of figures
FIG 1. Global Healthcare Nanotechnology Nanomedicine market, research methodology
FIG 2. Global Healthcare Nanotechnology Nanomedicine market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Healthcare Nanotechnology Nanomedicine market, key trends 2019
FIG 5. Global Healthcare Nanotechnology Nanomedicine market, growth prospects 2020-2027
FIG 6. Global Healthcare Nanotechnology Nanomedicine market, porters 5 force model
FIG 7. Global Healthcare Nanotechnology Nanomedicine market, pest analysis
FIG 8. Global Healthcare Nanotechnology Nanomedicine market, value chain analysis
FIG 9. Global Healthcare Nanotechnology Nanomedicine market by segment, 2017 & 2027 USD Billion
FIG 10. Global Healthcare Nanotechnology Nanomedicine market by segment, 2017 & 2027 USD Billion
FIG 11. Global Healthcare Nanotechnology Nanomedicine market by segment, 2017 & 2027 USD Billion
FIG 12. Global Healthcare Nanotechnology Nanomedicine market by segment, 2017 & 2027 USD Billion
FIG 13. Global Healthcare Nanotechnology Nanomedicine market by segment, 2017 & 2027 USD Billion
FIG 14. Global Healthcare Nanotechnology Nanomedicine market, regional snapshot 2017 & 2027
FIG 15. North America Healthcare Nanotechnology Nanomedicine market 2017 & 2027 USD Billion
FIG 16. Europe Healthcare Nanotechnology Nanomedicine market 2017 & 2027 USD Billion
FIG 17. Asia pacific Healthcare Nanotechnology Nanomedicine market 2017 & 2027 USD Billion
FIG 18. Latin America Healthcare Nanotechnology Nanomedicine market 2017 & 2027 USD Billion
FIG 19. Global Healthcare Nanotechnology Nanomedicine market, company market share analysis 2019


RELATED REPORTS



CHOOSE A FORMAT


  • $ 4950
  • $ 6250



Do you have any Queries ?



TESTIMONIALS

I am completely satisfied with the information given in the sample pages of the report and I am waiting for the affirmative response from my peers and colleagues to purchase it.hey answered to all my queries promptly. I am highly satisfied!!
Andrew Keats
We received a very quick response to all our queries on the RTLS report and we were also given a free consult with analyst for 15 minutes. It is refreshing (and increasingly rare) to have a new company go the extra mile to win the confidence of the customer
Pascal Kim
I would like to express my gratitude for the excellent service received this morning from the support team. They acknowledged my concern of adding me to the secondary user's list immediately. Thank you for this excellent, speedy and thoughtful service
Ivan Mezia


CUSTOM RESEARCH

Still haven't found what you're looking for ?
Speak to our Custom Research Team